SCHEMBL2181675

SCHEMBL2181675

CN(C)CCNCCNc1nnc2c(n1)c(=O)n(C)c(=O)n2C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.49
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 3/20 0.35
LMNA P02545 3/20 0.35
HTT P42858 2/20 0.35
JAK2 O60674 1/20 0.35
HPGD P15428 1/20 0.35
PAX8 Q06710 1/20 0.35
HSD17B10 Q99714 4/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
MAPT P10636 2/20 0.33
POLB P06746 2/20 0.33
ADORA2A P29274 2/20 0.33
THRB P10828 2/20 0.33
BLM P54132 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179921 0.92 CYP2D6 (0.56) CYP2D6CYP2C19L3MBTL1MAPK1SMN1; SMN2
SCHEMBL2183306 0.88 TP53 (0.41) CYP2D6CYP2C19L3MBTL1ALDH1A1KDM4E
SCHEMBL2183080 0.88 CYP2D6 (0.48) CYP2D6CYP2C19L3MBTL1MAPK1SMN1; SMN2
SCHEMBL2182670 0.85 CYP2C19 (0.42) CYP2C19MAPK1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL2180415 0.84 CYP2D6 (0.37) CYP2D6L3MBTL1MAPK1JAK2ADORA2A
SCHEMBL3264966 0.82 TP53 (0.41) CYP2D6CYP2C19L3MBTL1MAPK1SMN1; SMN2
SCHEMBL2184364 0.82 ALDH1A1 (0.38) CYP2D6SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL2181498 0.82 CYP2C19 (0.46) CYP2D6CYP2C19L3MBTL1MAPK1SMN1; SMN2
SCHEMBL2181663 0.80 CYP2D6 (0.48) CYP2D6CYP2C19L3MBTL1MAPK1SMN1; SMN2
SCHEMBL2183395 0.80 TP53 (0.47) CYP2D6CYP2C19L3MBTL1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed
WO-2010014798-A2 PYRIMIDOTRIAZINEDIONES AND PYRIMIDOPYRIMIDINEDIONES AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR CYP2D6 125/4885CYP2C19 381/4885L3MBTL1 4659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.